accessibility menu, dialog, popup

UserName
Viewing profile as user:

Gallic Acid

Gallic acid is a naturally-occurring trihydroxybenzoic acid. Available in various quantities, it is an astringent, a cyclooxygenase 2 inhibitor, an antioxidant, an antineoplastic agent, a weak carbonic anhydrase inhibitor, an apoptosis inducer, etc.

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (3)

special interests

  • (3)
Search Within Results
Keyword Search:
1 – 3 of 3 results
1

Medchemexpress LLC Tegoprazan | 942195-55-3 | MFCD30533430 | 99.8% | 387.38 g/mol | C20H19F2N3O3 | 10 MG
SDP

Tegoprazan is a potassium-competitive acid blocker (P-CAB) provided as a high-purity research reagent for studies of gastric acid regulation and related pharmacology. It is intended for in vitro assays and preclinical investigations and is supplied with analytical characterization to support research use.

  • High-purity reference compound for biochemical and cellular assays.
  • Potassium-competitive acid blocker mechanism relevant to acid suppression studies.
  • Suitable for in vitro and preclinical pharmacology investigations.
  • Comes with analytical documentation including purity and structural identifiers.
  • Stable solid form convenient for handling and storage.
  • Available in small research quantities for dose-ranging experiments.

ENCOMPASS_PREFERRED
2

Medchemexpress LLC Tegoprazan | 942195-55-3 | 99.8% | 387.38 | 100 MG
SDP

Tegoprazan is a potassium-competitive acid blocker, a reversible, orally active, and highly selective inhibitor of gastric H+/K+-ATPase. It inhibits gastric acid secretion and motility against porcine, canine, and human H+/K+-ATPase with IC50 values ranging from 0.29-0.52 μM in vitro. It also significantly improves colitis and enhances the intestinal epithelial barrier function in mice, making it promising for research of inflammatory bowel, gastric acid-related, and motility-impaired diseases.

  • Reversible, orally active, and highly selective inhibitor of gastric H+/K+-ATPase.
  • Inhibits gastric acid secretion and motility.
  • Improves colitis and enhances intestinal epithelial barrier function.
  • Promising for research of inflammatory bowel, gastric acid-related, and motility-impaired diseases.

ENCOMPASS_PREFERRED
3

Medchemexpress LLC Tegoprazan | 942195-55-3 | 387.38 | 50 MG
SDP

Tegoprazan is a potassium-competitive acid blocker, functioning as a reversible, orally active, and highly selective inhibitor of gastric H+/K+-ATPase. It inhibits gastric acid secretion and motility with in vitro IC50 values ranging from 0.29-0.52 μM. This compound has demonstrated the ability to significantly improve colitis and enhance intestinal epithelial barrier function in mice.

  • Reversible, orally active, and highly selective inhibitor of gastric H+/K+-ATPase
  • Inhibits gastric acid secretion and motility
  • Improves colitis
  • Enhances intestinal epithelial barrier function
  • Promising for research related to inflammatory bowel disease
  • Promising for research related to gastric acid-related diseases
  • Promising for research related to motility-impaired diseases

ENCOMPASS_PREFERRED